Every action is for the sake of patients.
Koyama’s first posting was to a branch in the suburbs of the Kanto region. Koyama says that Chugai Pharmaceutical respects what its MRs want to do even in their junior years. ‘In about my third year with the company, my job was to provide information on an osteoporosis drug to orthopedic specialists. However, this drug had the potential for serious adverse drug reactions during dental treatment. Because of this, I approached the local dentists’ association and planned and held a workshop for dentists. The orthopedic specialists were also happy that the risks to their patients had been reduced.When I consulted with my boss about holding the workshop, he encouraged me, saying that, even if it was not an activity that would produce immediate results, I should do it for the patients’ sake. This is a very typical Chugai Pharmaceutical stance and one that really boosted my motivation toward my work.’
Swaying doctors with conviction and passion.
Koyama called on the doctor many times and continued to advocate the value of this drug with conviction. The doctor was eventually swayed by Koyama’s determination and finally decided to use the drug. ‘That instant, when the doctor and I were of the same mind, was a precious moment for me. The doctor passionately persuaded the patient to take the drug, and the patient agreed, so this was also a case in which I was able to be of great service to patients. After successfully persuading the patient, the doctor called me immediately to let me know that the patient would be taking the drug. I still vividly remember that moment when we shared that sense of joy.’ Building up a track record of successful experiences such as this, Koyama continues to grow as an MR.
Eliminating healthcare disparities within the region to deliver appropriate treatment to all patients.
Koyama has now set her sights at a higher level and is striving to enhance the quality of treatment throughout the entire region. ‘One of my healthcare institution accounts is a hemophilia hospital that serves as a base for the region. Although hemophilia is a serious disease, there are disparities in the treatment available to patients depending on the hospitals and doctors that are treating them. I felt that this situation was problematic. When I expressed my concerns about this problem to an influential doctor at the hemophilia hospital, he strongly agreed with me, so we started working together to support hospitals in the region that were not doing as well with the diagnosis and treatment of hemophilia as they would like. As a result of our efforts, an environment was established in which every hospital in the region is able to deliver proper treatment for hemophilia. I believe we were able to make a significant impact with this initiative.’
This kind of energetic performance by Koyama is buoyed by a strong system of support for MRs’ activities within the company. If MRs have any concerns in the course of communicating with doctors, they can immediately ask in-house experts about adverse drug reaction information and academic information and obtain the answers they need. Moreover, Chugai Pharmaceutical has specialist MRs who have highly advanced knowledge in specific disease domains. MRs can coordinate with these specialists to provide information of even higher quality. ‘When I joined the company, I had heard that Chugai Pharmaceutical MRs work together to achieve their goals, and this really was the case. Because I can obtain the support of experts in various fields, I can take on new challenges without hesitation. There is also a corporate culture that encourages such challenges.’ At the heart of that culture is a consideration for patients. The fact that, no matter the situation, that consideration never wavers is, Koyama believes, the most appealing feature of Chugai Pharmaceutical.
*The contents of this article, and the divisions that the people featured in this article belonged to and the names of those divisions are current as of the time of the interview.